View Harpoon Therapeutics HARP investment & stock information. Delayed 15 minutes; NASDAQ. Harpoon Therapeutics - Crunchbase Company Profile & Funding The Investor Relations website contains information about Harpoon Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts. Harpoon Therapeutics Inc has a Bearish sentiment reading. Why Harpoon is seeking energetic, passionate scientists and innovators to join our effort. Trending now. Harpoon Therapeutics Inc. Harpoon Therapeutics, Inc. operates as a biotechnology company. Insider Buys Harpoon Therapeutics's Shares | Benzinga Harpoon Therapeutics, Inc. (HARP) delivered earnings and revenue surprises of -43.48% and 38.50%, respectively, for the quarter ended December 2021. HARPOON THERAPEUTICS, INC. : Target Price Consensus and However, as a result of recent losses, their initial investment is now only worth HARP Short Interest Ratio and Volume (Harpoon Therapeutics) Find real-time HARP - Harpoon Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. S&P 500 0.00%. NASDAQ 0.00%. Luke Evnin and Patrick Baeuerle step down from the Harpoon board. Harpoon Therapeutics Inc (NASDAQ:HARP) was trading 5.5% higher from the previous closing price. Year. Short sellers are betting that Harpoon Therapeutics will decline in price. ONTX finished a public offering. The S&P 500 bank index has fallen almost 25% so far this year compared with a drop of roughly 19% for the benchmark S&P 500. Read More. 8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Harpoon Therapeutics in the last twelve months. Harpoon Therapeutics, Inc. (NASDAQ:HARP) shareholders might be concerned after seeing the share price drop 13% in the last month. Price Action: HARP shares are down 24.3% at $15.86 during Harpoon Therapeutics Stock - EquityZen This does raise concerns about the companys platform, and the rest of their pipeline programs. View our latest analysis for Harpoon Therapeutics Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the smaller ones. HARP: Harpoon Therapeutics Inc Stock Price Quote - Bloomberg HARP : 2.10 (-6.25%) Harpoon Therapeutics, Inc. (HARP) Reports Q4 Loss, Lags Revenue Estimates Zacks - Thu Mar 10, 4:45PM CST. The stock has a 50 day moving average price of $0.28 and a 200-day moving average price of $0.40. Why did Harpoon Therapeutics stock go down today? Stock Quote & Chart | Harpoon Therapeutics, Inc. To short Harpoon Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Odonate Therapeutics (NASDAQ: ODT) shares were trading lower on Monday after the company announced the results from CONTESSA, a Phase 3 study of Tesetaxel, achieved the primary endpoint. The company's pipeline products include HPN424, HPN536, HPN217, and others. Phone Number 650-443-7400. It is engaged in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. HARP - Harpoon Therapeutics Inc Stock quote - CNNMoney.com Harpoon Therapeutics'(NASDAQ:HARP) Share Price Is Down 13 Sign Up. Harpoon Therapeutics is not the only stock insiders are buying. The business earned $5.91 million during the quarter, compared to analysts' expectations of $11.31 million. In depth view into HARP (Harpoon Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. Rooms Rankings Earnings Newsletters Shop. Some data provided by Crunchbase. News Releases | Harpoon Therapeutics, Inc. Drs. Harpoon Therapeutics is a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the bodys immune system to treat patients suffering from cancer and other diseases. HRTX Heron Therapeutics Inc Stock Price and August 10, 2022. Cancel. Their HARP share price forecasts range from $7.00 to $18.00. On average, they expect the company's share price to reach $12.89 in the next twelve months. This suggests a possible upside of 496.7% from the stock's current price. View analysts price targets for HARP or view top-rated stocks among Wall Street analysts. Contact Email bd@harpoontx.com. finance.yahoo.com - May 2 at 1:47 PM. Harpoon's management will host a webcast and conference call today at 4 p.m. Learn More (HARP) - Harpoon Therapeutics Stock Drops After Careers. Insiders who bought this year lost US$50k as Harpoon Therapeutics, Inc. (NASDAQ:HARP) sheds US$30m in value. Harpoon Therapeutics' stock is trading down $0.16 today. Harpoon Therapeutics Market Digest: GILD, GPS, JBLU, LRCX, NUE, STX, RTX, MA, CFG Stocks gave up strong early gains on Thursday, ending in the red after initially rallying on much better-than-expected economic data. The Commerce Department said that the U.S. economy expanded at a 6.9% rate in 4Q, up strongly from the prior quarter and well above the consensus forecast. Harpoon Therapeutics Company Profile: Stock Performance Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. Learn More. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. View real-time stock prices and stock quotes for a full financial overview. Currency In USD. Harpoon Therapeutics Inc - Company Profile and News